» Articles » PMID: 7573250

Chronic Fungal Vaginitis: the Value of Cultures

Overview
Publisher Elsevier
Date 1995 Sep 1
PMID 7573250
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our purpose was to examine the importance of fungal cultures in evaluating patients with symptoms of chronic vaginitis by assessing the relative contribution of various yeast species and by comparing infections caused by Candida albicans with those caused by other species.

Study Design: A prospective observational study of patients referred with chronic vaginal symptoms was undertaken. In addition to a standard evaluation of symptoms, cultures for yeast were performed on modified Sabouraud agar plates.

Results: Seventy-seven isolates were obtained from 74 patients. A total of 68% were Candida albicans; 32% were other species. The clinical syndromes caused by non-Candida albicans isolates were indistinguishable from Candida albicans infections. Fluconazole gave a short-term mycologic cure in all Candida albicans but only 25% of non-Candida albicans cases (p < 0.001). In non-Candida albicans infections, boric acid suppositories achieved the best mycologic cure rate (85%).

Conclusion: Because non-Candida albicans species are responsible for a significant number of chronic fungal vaginal infections and are more resistant to therapy with fluconazole, fungal cultures are a valuable aid in confirming the diagnosis and selecting appropriate therapy.

Citing Articles

Antifungal susceptibility testing and determination of local epidemiological cut-off values for species isolated from women with vulvovaginal candidiasis.

Kroustali V, Kanioura L, Resoulai E, Siopi M, Antonopoulou S, Meletiadis J Microbiol Spectr. 2025; 13(3):e0248824.

PMID: 39846759 PMC: 11878056. DOI: 10.1128/spectrum.02488-24.


Candida albicans-induced activation of the TGF-β/Smad pathway and upregulation of IL-6 may contribute to intrauterine adhesion.

Zhao X, Sun D, Zhang A, Huang H, Li Y, Xu D Sci Rep. 2023; 13(1):579.

PMID: 36631456 PMC: 9834405. DOI: 10.1038/s41598-022-25471-0.


Prevalence of Pathogens and Other Microorganisms in Premenopausal and Postmenopausal Women with Vulvovaginal Symptoms: A Retrospective Study in a Single Institute in South Korea.

Baek J, Jo H, Lee S, Park J, Cho I, Sung J Medicina (Kaunas). 2021; 57(6).

PMID: 34199976 PMC: 8229179. DOI: 10.3390/medicina57060577.


Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Farr A, Effendy I, Tirri B, Hof H, Mayser P, Petricevic L Geburtshilfe Frauenheilkd. 2021; 81(4):398-421.

PMID: 33867561 PMC: 8046514. DOI: 10.1055/a-1345-8793.


Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).

Farr A, Effendy I, Tirri B, Hof H, Mayser P, Petricevic L Mycoses. 2021; 64(6):583-602.

PMID: 33529414 PMC: 8248160. DOI: 10.1111/myc.13248.